GlassScriptPhysician profile
Frazier Earl Fyke
NPI 1780609362
$3,858.97
in general payments reported to CMS, 2019-2025
26 companies · $429 in 2025
The $429 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $331 · 2021: $957 · 2022: $755 · 2023: $733 · 2024: $199 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,360.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $850.12 | 2020-2023 | Gallant, Confirm Rx, Assurity |
| Novartis Pharmaceuticals Corporation | $760.93 | 2019-2023 | |
| Boston Scientific Corporation | $388.80 | 2019-2024 | Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $246.28 | 2021-2022 | |
| Amgen INC. | $175.87 | 2019-2023 | Repatha |
| Acist Medical Systems, INC. | $149.45 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $148.20 | 2021-2023 | |
| Inspire Medical Systems, INC. | $132.41 | 2025 | Inspire |
| Chiesi USA, INC. | $122.81 | 2019-2025 | Kengreal |
| Novo Nordisk INC | $105.85 | 2023-2025 | Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals LP | $100.73 | 2022-2024 | Wainua |
| Merck Sharp & Dohme LLC | $96.91 | 2022-2023 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $91.77 | 2025 | Evkeeza |
| Alnylam Pharmaceuticals INC. | $83.13 | 2022-2023 | Onpattro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $77.46 | 2019-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $62.26 | 2022-2023 | Micra, Cobalt Dr Mri Surescan |
| Abiomed | $48.80 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $48.61 | 2019-2022 | |
| Medtronic Vascular, INC. | $43.12 | 2019-2020 | |
| Akcea Therapeutics, INC. | $26.51 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $23.91 | 2020 | |
| Impulse Dynamics (USA) INC. | $21.89 | 2023 | Optimizer |
| Sanofi-Aventis U.S. LLC | $14.44 | 2019 | |
| Terumo Medical Corporation | $14.37 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $13.55 | 2023 | Opsumit, Uptravi |
| Pfizer INC. | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frazier Fyke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.